Adaptimmune Therapeutics PLC poised for growth. Cramer predicts $100B+ value on FDA approval. Potential 300% upside? In-depth company & stock analysis. Discover why the Stocktwits app got deleted and stay updated on ADAP stock trends. Stay tuned for market insights and investment opportunities.